To determine whether ceramide analogs regulate FasL-induced activation of MAPK and NF-κB in human colon carcinoma cells, SW480 and RKO cells were treated with FasL and ceramide analog IG7. This evidence concerns the gene NFKB1 and colon carcinoma.